Physician profile
Jordan Gross
NPI 1477931137
$83,580.15
in general payments reported to CMS, 2019-2025
13 companies · $77K in 2025
The $77K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $27.25 · 2021: $2,925 · 2022: $166 · 2023: $2,555 · 2024: $876 · 2025: $77K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $75K · Travel and Lodging: $3,471 · Food and Beverage: $1,944 · Education: $46.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $75,000.00 |
| Travel and Lodging | $3,470.68 |
| Food and Beverage | $1,944.11 |
| Education | $46.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linkbio Corp | $75,000.00 | 2025 | |
| Stryker Corporation | $3,895.82 | 2020-2025 | Everest Spinal System, Spinemap, Yukon Oct Spinal System |
| Nuvasive, INC. | $1,692.48 | 2021 | |
| Zimmer Biomet Holdings, INC. | $1,636.45 | 2025 | Oxford, Avenir |
| Medacta USA, INC. | $588.68 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $241.00 | 2024-2025 | Exparel |
| Orthofix Medical, INC. | $142.92 | 2022 | |
| Novus Surgical Consultants | $128.68 | 2025 | |
| Curonix LLC | $118.55 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abiomed | $51.69 | 2023 | Impella |
| Globus Medical, INC. | $36.89 | 2023 | Creo 5.5 |
| Uoc USA INC | $23.58 | 2024 | Psa, Locking Cage and Ustar II |
| Medtronic, INC. | $23.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Gross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.